Health Care: Health Services

West Pharmaceutical Services Inc. (WST: NYSE)

$67.49 -0.68 | -1.00%
06/19/13 - 04:01 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 1.27B 1.19B 1.10B 1.06B
Cost of Sales 801.80M 777.30M 713.40M 684.00M
Gross Operating Profit 464.60M 415.00M 391.30M 371.70M
Selling, General, and Administrative Expenses 218.10M 191.10M 187.70M 177.70M
Research & Development 33.20M 29.10M 23.90M 19.90M
Operating Income before D & A (EBITDA) 213.30M 194.80M 179.70M 174.10M
Depreciation & Amortization 76.90M 75.70M 73.20M 68.10M
Interest Income 1.80M 1.30M 600.00K 800.00K
Other Income - Net -6.80M 6.30M 4.40M 3.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 130.10M 117.20M 95.70M 101.30M
Interest Expense 16.70M 18.20M 16.80M 15.20M
Pre-Tax Income 113.40M 99.00M 78.90M 86.10M
Income Taxes 32.70M 23.50M 13.60M 13.50M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 80.70M 75.50M 65.30M 72.60M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 80.70M 75.50M 65.30M 72.60M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 80.70M 75.50M 65.30M 72.60M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
82.00M 85.00M 81.10M 81.10M
Preferred Dividends
Net Income Available To Common 80.70M 75.50M 65.30M 72.60M
Basic EPS from Continuing Ops. 2.37 2.24 1.96 2.21
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.37 2.24 1.96 2.21
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.37 2.24 1.96 2.21
Basic Normalized Net Income/Share 2.41 2.52 2.43 2.47
EPS fr Continuing Ops. 2.30 2.16 1.89 2.12
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.30 2.16 1.89 2.12
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.30 2.16 1.89 2.12
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.34 2.43 2.35 2.37
Dividends Paid per Share 0.73 0.69 0.65 0.61

Portfolios with WST

Latest WST Headlines from TheStreet

More Financial News for WST

Press Releases for WST

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter